NDC properties for "Hyrimoz 40 MG per 0.4 ML Prefilled Syringe" (RxCUI 2641661)
About this data
The tables show NDC propoerties for Hyrimoz 40 MG per 0.4 ML Prefilled Syringe with the RxCUI 2641661
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for Hyrimoz 40 MG per 0.4 ML Prefilled Syringe (RxCUI 2641661)
BLA | BLA761071 |
---|---|
MMSL_CODE | BD39595 |
RxCUI | 2641661 |
SPL_SET_ID | 1ac7d061-3380-468c-b077-c05f8dfbc829 |
SPL_SET_ID | 3e303a4a-980b-4f2a-9d03-786928758637 |
Prescribable Synonym | Hyrimoz 40 MG in 0.4 ML Prefilled Syringe |
RXNAV_STR | Hyrimoz 40 MG per 0.4 ML Prefilled Syringe |
RxNorm Name | 0.4 ML adalimumab-adaz 100 MG/ML Prefilled Syringe [Hyrimoz] |
RxNorm Synonym | Hyrimoz 40 MG per 0.4 ML Prefilled Syringe |
Related queries | Interactions (for RxCUI 2641661) |
NDC Properties
NDC Item 61314047364
NDC 9 | 61314-473 |
---|---|
NDC 10 | 61314-473-64 |
NDC Item | 61314047364 |
Packaging | 2 SYRINGE, GLASS in 1 CARTON (61314-473-64) / .4 mL in 1 SYRINGE, GLASS |
BLA | BLA761071 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | BLA |
Marketing effective time low | 2023-07-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 61314-473 |
NDC Item 83457010101
NDC 9 | 83457-101 |
---|---|
NDC 10 | 83457-101-01 |
NDC Item | 83457010101 |
Packaging | 2 SYRINGE, GLASS in 1 CARTON (83457-101-01) / .4 mL in 1 SYRINGE, GLASS |
BLA | BLA761071 |
Labeler | Cordavis Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | BLA |
Marketing effective time low | 2023-09-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 83457-101 |
NDC Item 83457020146
NDC 9 | 83457-201 |
---|---|
NDC 10 | 83457-201-46 |
NDC Item | 83457020146 |
Related queries | Properties for NDC 9 83457-201 |
NDC Item 61314047364
NDC 9 | 61314-473 |
---|---|
NDC 10 | 61314-473-64 |
NDC Item | 61314047364 |
Packaging | 2 SYRINGE, GLASS in 1 CARTON (61314-473-64) / .4 mL in 1 SYRINGE, GLASS |
BLA | BLA761071 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | BLA |
Marketing effective time low | 2023-07-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 61314-473 |
NDC Item 83457010101
NDC 9 | 83457-101 |
---|---|
NDC 10 | 83457-101-01 |
NDC Item | 83457010101 |
Packaging | 2 SYRINGE, GLASS in 1 CARTON (83457-101-01) / .4 mL in 1 SYRINGE, GLASS |
BLA | BLA761071 |
Labeler | Cordavis Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | BLA |
Marketing effective time low | 2023-09-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 83457-101 |
NDC Item 83457020146
NDC 9 | 83457-201 |
---|---|
NDC 10 | 83457-201-46 |
NDC Item | 83457020146 |
Related queries | Properties for NDC 9 83457-201 |
NDC Item 61314047364
NDC 9 | 61314-473 |
---|---|
NDC 10 | 61314-473-64 |
NDC Item | 61314047364 |
Packaging | 2 SYRINGE, GLASS in 1 CARTON (61314-473-64) / .4 mL in 1 SYRINGE, GLASS |
BLA | BLA761071 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | BLA |
Marketing effective time low | 2023-07-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 61314-473 |
NDC Item 83457010101
NDC 9 | 83457-101 |
---|---|
NDC 10 | 83457-101-01 |
NDC Item | 83457010101 |
Packaging | 2 SYRINGE, GLASS in 1 CARTON (83457-101-01) / .4 mL in 1 SYRINGE, GLASS |
BLA | BLA761071 |
Labeler | Cordavis Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | BLA |
Marketing effective time low | 2023-09-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 83457-101 |
NDC Item 83457020146
NDC 9 | 83457-201 |
---|---|
NDC 10 | 83457-201-46 |
NDC Item | 83457020146 |
Related queries | Properties for NDC 9 83457-201 |